SanoculisSanoculis
Sanoculis

Sanoculis

2012Active10

About

MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization. • A novel Glaucoma treatment • Leaves nothing behind (stent-less) thus lowering the risk of complications • Can be easily combined with Cataract surgery • Medication-sparing which improves patients' quality of life

Technology stack

detected 2026-06-16
Est. monthly stack spend~$140/mo
CDN
Cloudflare
EmailGoogle Workspace
Stack
jQueryShopify
A11y
UserWay
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Sanoculis do?

MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization. • A novel Glaucoma treatment • Leaves nothing behind (stent-less) thus lowering the risk of complications • Can be easily combined with Cataract surgery • Medication-sparing w…

When was Sanoculis founded?

Sanoculis was founded in 2012.

What industry does Sanoculis operate in?

Sanoculis operates in Healthcare.

How many employees does Sanoculis have?

Sanoculis has approximately 10 people on record.